Send us Fan Mail As a result of the rapid adoption CAR-T therapy for certain lymphoid malignancies and multiple myeloma, of these treatments, CRS and ICANS will become more common in IM wards in the coming years. Take a listen to learn about how to treat this emerging condition. This episode was written by Dr. Veronica Ramirez (Internal Medicine Resident) ... Show More
Sep 27
Not Just Wear & Tear: Approach to Osteoarthritis
Send us Fan MailOsteoarthritis may not just be inevitable wear and tear of a joint. In this episode, we break down osteoarthritis, exploring joint mechanics, clinical presentation, and relevant investigations. Written by Dr. Aarabi Thayaparan (Internal Medicine resident at Queen' ... Show More
13m 22s
Sep 13
Tracing the Leak: An Approach to Proteinuria
Send us Fan MailIn this episode, we break down an approach to proteinuria, focusing on the interpretation of the urine dipstick, the urine ACR, and the urine PCR. Written by Dr. Ishmam Bhuiyan (Internal Medicine Resident at UBC). Reviewed by Dr. Teresa Tai (General Internist at R ... Show More
14m 32s
Aug 2022
Jason Westin, MD, MS, FACP - Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
Go online to PeerView.com/NMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chimeric antigen receptor T-cell (CAR T) therapy, a validated novel therapeutic strategy in leukemic and lymphoid malignancies, continues to provid ... Show More
1h 30m
Aug 2024
CAR T-cell Therapy in AML: State of the Art
Tune in to our podcast for an in-depth discussion on immunotherapeutic strategies for Acute Myeloid Leukemia (AML). In this episode, we feature Dr Sarah Tettamanti, a senior scientist at the Fondazione Tettamanti Research Centre in Italy, who shares her expertise on CAR T-cell th ... Show More
15m 1s
Sep 2023
Episode 075: Intro to CAR-T, Bispecifics (BiTE), and Autologous Transplant
<p class="" style="white-space:pre-wrap;">In this week’s episode, we pause from our discussion about DLBCL to talk about the fundamentals of CAR-T, BiTE and autologous transplants, which will lay the foundation for subsequent discussions about DLBCL. These therapies are the talk ... Show More
26m 55s
Sep 2025
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ... Show More
36m 11s
Sep 2025
S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ... Show More
24m 38s